Unknown

Dataset Information

0

Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.


ABSTRACT: Ewing sarcomas (ES) are highly malignant bone or soft tissue tumors. Genetically, ES are defined by balanced chromosomal EWS/ETS translocations, which give rise to chimeric proteins (EWS-ETS) that generate an oncogenic transcriptional program associated with altered epigenetic marks throughout the genome. By use of an inhibitor (JQ1) blocking BET bromodomain binding proteins (BRDs) we strikingly observed a strong down-regulation of the predominant EWS-ETS protein EWS-FLI1 in a dose dependent manner. This was further enhanced by co-treatment with an inhibitor of the PI3K pathway. Microarray analysis further revealed JQ1 treatment to block a typical ES associated expression program. The effect on this expression program was mimicked by RNA interference with BRD3 or BRD4 expression, indicating that the EWS-FLI1 mediated expression profile is at least in part mediated via such epigenetic readers. Consequently, contact dependent and independent proliferation of different ES lines was strongly inhibited. Mechanistically, treatment of ES resulted in a partial arrest of the cell cycle as well as induction of apoptosis. Tumor development was suppressed dose dependently in a xeno-transplant model in immune deficient mice, overall indicating that ES may be susceptible to treatment with epigenetic inhibitors blocking BET bromodomain activity and the associated pathognomonic EWS-ETS transcriptional program.

SUBMITTER: Hensel T 

PROVIDER: S-EPMC4811472 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.

Hensel Tim T   Giorgi Chiara C   Schmidt Oxana O   Calzada-Wack Julia J   Neff Frauke F   Buch Thorsten T   Niggli Felix K FK   Schäfer Beat W BW   Burdach Stefan S   Richter Günther H S GH  

Oncotarget 20160101 2


Ewing sarcomas (ES) are highly malignant bone or soft tissue tumors. Genetically, ES are defined by balanced chromosomal EWS/ETS translocations, which give rise to chimeric proteins (EWS-ETS) that generate an oncogenic transcriptional program associated with altered epigenetic marks throughout the genome. By use of an inhibitor (JQ1) blocking BET bromodomain binding proteins (BRDs) we strikingly observed a strong down-regulation of the predominant EWS-ETS protein EWS-FLI1 in a dose dependent man  ...[more]

Similar Datasets

2015-12-08 | E-GEOD-72673 | biostudies-arrayexpress
2015-12-08 | GSE72673 | GEO
| S-EPMC7072515 | biostudies-literature
2018-06-19 | GSE113604 | GEO
| S-EPMC4155010 | biostudies-literature
| S-EPMC5190040 | biostudies-literature
| PRJNA453371 | ENA
| S-EPMC6497538 | biostudies-literature
| S-EPMC6125457 | biostudies-literature
2019-03-31 | GSE119546 | GEO